PECAM1 and transient ischemic attack: The results showed that the number of CD31+ microvessels in the ischemic hemisphere of the NBP-treated group was significantly increased at 7 and 14 days post-MCAO compared to those of the vehicle-treated group (p < 0.01; Figure 6A), indicating that NBP promoted angiogenesis in TIA mice.